BioHarvest Sciences Inc.: BioHarvest Sciences Reports 2022 Sales Orders of USD 6.1M Representing 2.6X Increase over 2021
Finished 2022 with Q4 sales orders of USD 2.7M representing a 3.3X increase over Q4 2021Sales orders growth for 2023 is projected to be 3X of 2022 and reach USD 17.3M - USD 20.3M Cash flow break even